Verona Pharma plc buy Wells Fargo & Company
Start price
05.11.24
/
50%
€0.51
Target price
05.11.25
€58.68
Performance (%)
-
End price
06.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -3,17 % | 1,23 % | 2,54 % |
| iShares Nasdaq 100 | -1,01 % | 0,38 % | 32,25 % |
| iShares Nikkei 225® | -3,60 % | 1,00 % | 59,53 % |
| iShares S&P 500 | 0,21 % | 2,92 % | 24,52 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $50.00 to $64.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten